Tech Company Financing Transactions
Orum Therapeutics Funding Round
IMM Investment, Atinum Investment and InterVest participated in a $84 million Series B funding round for Orum Therapeutics. The financing round was announced by the company on 6/24/2021.
Transaction Overview
Company Name
Announced On
6/24/2021
Transaction Type
Venture Equity
Amount
$84,000,000
Round
Series B
Investors
Proceeds Purpose
Orum plans to use the proceeds to advance the Company's lead therapeutic candidates into clinical trials, explore additional payload chemistries to develop additional payloads that modulate the ubiquitin pathway, and other general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Acorn Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies to bring new medicines to patients with unmet medical needs. Orum leverages its unique cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
SJ Lee
Chief Scientific Officer
Peter Park
Browse more venture capital transactions:
Prev: 6/24/2021: TheLoops venture capital transaction
Next: 6/24/2021: Merlyn Mind venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs